BIOTECHNOLOGY VALUE FUND L P - 31 Mar 2025 SCHEDULE 13G/A Report for TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share
Symbol
TCRX
Shares outstanding
52,688,098 shares
Disclosed Ownership
5,263,541 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:40:26 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 6.4% 3,351,425 0 3,351,425 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 6.4% 3,351,425 0 3,351,425 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 2.9% 1,505,307 0 1,505,307 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 2.9% 1,505,307 0 1,505,307 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.6% 306,903 0 306,903 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.6% 306,903 0 306,903 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.2% 4,856,732 0 4,856,732 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 10% 5,263,541 0 5,263,541 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 10% 5,263,541 0 5,263,541 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 10% 5,263,541 0 5,263,541 /s/ Mark N. Lampert Mark N. Lampert